Vaccine Progress and What’s Next
Exchanges at Goldman Sachs
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.Next Episodes
Client Call: Macro Outlook 2021 @ Exchanges at Goldman Sachs
📆 2020-11-09 23:16 / ⌛ 00:56:21
Markets Update: Investors Feel “Relief” As Clarity Begins to Form Around US Election @ Exchanges at Goldman Sachs
📆 2020-11-06 20:43 / ⌛ 00:10:13
Markets Update: Investors Anticipate Next Week’s US Election @ Exchanges at Goldman Sachs
📆 2020-10-30 12:17 / ⌛ 00:10:49
How Entrepreneurs are Leading Their Companies Through an Unexpected Year @ Exchanges at Goldman Sachs
📆 2020-10-27 14:41 / ⌛ 00:36:14
Markets Update: Election Outlook @ Exchanges at Goldman Sachs
📆 2020-10-22 20:00 / ⌛ 00:11:33